Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-245-9 | CAS number: 10099-74-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 January 2014 - 17 February 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- Environmental parameters: A temperature of 17°C was registered on 20 January 2014 instead of 19°C (minimal value) as planned in the study plan. This deviation did not in any case influence the result and the development of this study.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/J (CBA/J@Rj)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Elevage Janvier Labs (F-53941 Le Genest Saint Isle, France)
- Age at study initiation: 8 weeks
- Weight at study initiation: 19.2 to 23.9 g
- Housing: Individually, in suspended solid-floor polypropylene cages furnished with softwood woodflakes. The animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study.
- Diet: food (A04, SAFE) was supplied freely
- Water: drinking water (tap water from public distribution system) was supplied freely
- Acclimation period: minimum 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): between 18°C and 23°C
- Humidity (%): between 38% and 60%
- Air changes (per hr): approximately thirteen changes per hour
- Photoperiod (hrs dark / hrs light): the lighting was controlled by a time switch to give twelve hours continuous light (07.00 to 19.00) and twelve hours darkness - Vehicle:
- dimethylformamide
- Concentration:
- 10%, 25%, 50%
- No. of animals per dose:
- 4 (An additional mouse was treated in each group in case of problem which may occur during the study, in particular during the excision of lymph nodes)
- Details on study design:
- PRELIMINARY STUDY
- Study design: As no information was available regarding irritant potential or systemic toxicity of the test item in the mouse, a preliminary screening test was performed using one mouse. The mouse was treated by application of 25 μL of the test item at 50% in Dimethylformamide to the dorsal surface of each ear for two days (Day 1 and Day 2). Any signs of toxicity or excessive local irritation noted during this period were recorded. Ear thickness and bodyweight of the mice were recorded on day 1 (prior to dosing).
- Observations: No mortality and no signs of systemic toxicity were noted at the concentration of 50%. As no sign of excessive irritation was noted at the concentration of 50%, this concentration was chosen as the highest concentration for the main studies.
MAIN STUDIES
Two experiments were performed.
- ANIMAL ASSIGNMENT: The animals were selected at random and given a number unique within the study by indelible ink-marking on the tail and a number written on a cage card.
- TREATMENT ADMINISTRATION: The mice were treated by daily application of 25 μL of the appropriate concentration of the test item to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test item formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- A study was performed to assess the sensitivity of the strain of mouse to a known sensitiser. Three groups, each of four animals, were treated with 50 μL (25 μL per ear) of α-Hexylcinnamaldehyde, as a solution in acetone/olive oil (4:1; v/v) (AOO) at concentrations of 5%, 10% and 25% (v/v). A further control group of four animals was treated with acetone/olive oil (4:1; v/v) alone. The Stimulation Index (SI) expressed as the cell count for each treatment group divided by the mean cell count of the vehicle control group are as follows: - 5% test item: SI 1.07 (negative) - 10% test item: SI 1.59 (positive) - 25% test item: SI 2.46 (positive) An EC1.4 value of 6.72% could be derived.
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- Experiment 1: The Stimulation Index (SI) calculated by pooled approach was 1.25, 1.51 and 1.13 for the treated groups at 10%, 25% and 50% respectively. The EC1.4 determined by linear regression was 18.65%. Experiment 2: To confirm these results, a second test was performed at the same concentrations. The Stimulation Index (SI) calculated by pooled approach was 1.92, 2.04 and 1.72 for the treated groups at 10%, 25% and 50% respectively. The EC1.4 could not be determined in this experiment.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- According to the OECD guideline, evaluation of LLNA results is based on the measurement of 3H- thymidine incorporation into the lymph node cells in the first place. However, it is stated that “other endpoints for assessment of proliferation may be employed provided there is justification and appropriate scientific support”. Lymph node cell count is more direct measurement of cell proliferation than determination of DNA synthetis and therefore considered an appropriate parameter for evaluation of cell proliferation in the assay. The internationally validated cut-off value for this method is SI=1.4 (instead of 3).
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: other: OECD 429
- Conclusions:
- In view of these results, under these experimental conditions, lead nitrate crystals must be classified as a skin sensitiser, in accordance with the criteria for classification, packaging and labelling of dangerous substances and preparations of the E.E.C. Directives 67/548, 2001/59 and 99/45. The item must be characterised by the symbol “Xi” and the warning label “Irritant” with the risk sentence R43 “May Cause Sensitisation by Skin Contact”.
In accordance with the Regulation EC No 1272/2008, the test item must be classified in category 1 “Skin sensitisation”, subcategory 1B. The signal word “Warning” and hazard statement H317 “May cause an allergic skin reaction” are required. - Executive summary:
A mouse local lymph node assay (LLNA) was performed to assess the skin sensitisation potential of lead nitrate crystals in the CBA/J mouse strain following topical applications to the dorsal surface of the ear.
Three groups of four animals were treated for three consecutive days (Day 1/2/3) with 50 μL (25 μL per ear) of the test item diluted in dimethyl formamide (DMF) at concentrations of 10%, 25% and 50% (w/w). A further group of four animals was treated with DMF.
On D6, the proliferation of lymphocytes in the draining auricular lymph nodes was determined by cell counting. The experimental protocol was established according tothe OECD Guideline No.429 dated 22 July 2010and the test method B.42 of the Council regulation No. 640/2012 of 06 July 2012.
Results of experiment 1
No mortality and no signs of systemic toxicity were noted in the test and control animals during the test. Slight dryness was noted on day 6 in all animals at the three concentrations. Remaining of the test item was noted on day 3 in all animals at 50%.
No significant increase in ear thickness and in ear weight was noted in animals treated at 10%, 25% and 50%. Therefore, the test item must be considered as not excessively irritant at these three concentrations.
The Stimulation Index (SI) calculated by pooled approach was 1.25, 1.51 and 1.13 for the treated groups at 10%, 25% and 50% respectively.
The EC1.4 determined by linear regression was 18.65%.Results of experiment 2
To infirm or confirm this results, a second test was performed at the same concentrations. No mortality and no signs of systemic toxicity were noted in the test and control animals during the second test. Remaining of the test item was noted on day 6 in all animals at 10% and 25%.
No significant increase in ear thickness and in ear weight was noted in animals treated at 10% and 50%. Therefore, the test item must be considered as not excessively irritant at these two concentrations. Slight increase in ear thickness (+14.2%) associated with a significant increase in ear weight, was noted in animals treated at 25% (+26.4%). Therefore, the test item must be considered as excessively irritant at this concentration.The Stimulation Index (SI) calculated by pooled approach was 1.92, 2.04 and 1.72 for the treated groups at 10%, 25% and 50% respectively.
The EC1.4 could not be determined in this experiment.In view of these results, under these experimental conditions, lead nitrate crystals must be classified as a skin sensitiser, in accordance with the criteria for classification, packaging and labelling of dangerous substances and preparations of the E.E.C. Directives 67/548, 2001/59 and 99/45. The item must be characterised by the symbol “Xi” and the warning label “Irritant” with the risk sentence R43 “May Cause Sensitisation by Skin Contact”.
In accordance with the Regulation EC No 1272/2008, the test item must be classified in category 1 “Skin sensitisation”, subcategory 1B. The signal word “Warning” and hazard statement H317 “May cause an allergic skin reaction” are required.
Reference
Clinical observations and mortality
No mortality and no signs of systemic toxicity were noted in the test and control animals during the test.
Weight evolution
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period.
Local irritation & Stimulation Index
1st experiment:
Slight dryness was noted on day 6 in all animals at the three concentrations. Remaining of the test item was noted on day 3 in all animals at 50%.
No significant increase in ear thickness and in ear weight was noted in animals treated at 10%, 25% and 50%. Therefore, the test item must be considered as not excessively irritant at these three concentrations.
Group | Test item | Excessive irritation (Y/N) | Cell count (x 106 cells/ml) | SI | result | EC1.4 |
1 | vehicle (DMF) | N | 31.44 | / | / | / |
2 | 10% | N | 39.24 | 1.25 | negative | 18.65% |
3 | 25% | N | 47.43 | 1.51 | positive | 18.65% |
4 | 50% | N | 35.42 | 1.13 | negative | 18.65% |
2nd experiment:
Remaining of the test item was noted on day 6 in all animals at 10% and 25%. No significant increase in ear thickness and in ear weight was noted in animals treated at 10% and 50%. Therefore, the test item must be considered as not excessively irritant at these two concentrations. Slight increase in ear thickness (+14.2%) associated with a significant increase in ear weight, was noted in animals treated at 25% (+26.4%). Therefore, the test item must be considered as excessively irritant at this concentration.
Group | Test item | Excessive irritation (Y/N) | Cell count (x 106cells/ml) | SI | result | EC1.4 |
1 | vehicle (DMF) | N | 20.73 | / | / | / |
2 | 10% | N | 39.77 | 1.92 | positive | / |
3 | 25% | Y | 42.39 | 2.04 | positive | / |
4 | 50% | N | 35.58 | 1.72 | positive | / |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
- Migrated from Short description of key information:
In a mouse local lymph node assay (LLNA), the skin sensitisation potential of lead nitrate crystals was investigated. The assay was repeated twice. In both experiments, a stimulation of lymphocyte proliferation was recorded at least at one concentration tested, without indications of excessive irritation at that concentration.
Justification for selection of skin sensitisation endpoint:
OECD 429 Guideline study, compliant with GLP
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
- Justification for selection of respiratory sensitisation endpoint:
Respiratory exposure to lead nitrate crystals is negligible because only 0.03% of the lead dinitrate particles are within the inhalable size limits (<10 µm) and therefore an acute inhalation test is not required (see IUCLID section 4.5 for discussion of the complete dustiness test)
Justification for classification or non-classification
- in accordance with EEC Directives 67/548, 2001/59 and 99/45: "May cause sensitisation by skin contact" (R43)
- in accordance with Regulation (EC) No 1272/2008: Category 1B "Skin sensitisation" with signal word "Warning" and hazard statement H317 "May cause allergic skin reaction".
Lead nitrate crystals should be classified as follows:
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.